Rickettsialpox
A rare acquired self-limiting infectious disease due to the mite-borne bacteria Rickettsia akari characterized by an asymptomatic 0.5 to 2 cm in diameter papulovesicle that typically ulcerates and forms an eschar followed by a generalized papulovesicular rash associating variable constitutional symptoms such as localized lymphadenopathy fever malaise and headaches. Additonal symptoms may include diaphoresis myalgia and less frequently rhinorrhea pharyngitis nausea vomiting splenomegaly conjunctival hyperemia and abdominal pain. Systemic symptoms resolve within 6-10 days.
Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.
Reference: Access aggregated data from Orphanet at Orphadata.
Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024
Newly diagnosed with
Rickettsialpox?
Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.
Clinical Trials
For a list of clinical trials in this disease area, please click here.